The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R03 | Drugs for obstructive airway diseases | |
| 3 | R03D | Other systemic drugs for obstructive airway diseases | |
| 4 | R03DA | Xanthines | |
| 5 | R03DA08 | Bamifylline |
| Active Ingredient | Description | |
|---|---|---|
| Bamifylline |
Bamifylline is a methylxanthinic derivative with two side chains in position 7 and 8, distinguishing it clearly from theophylline. Bamifylline carries out a bronchospasmolytic action on the smooth musculature and also blocks the action of the bronchoconstriction mediators. Unlike theophylline, bamifylline usually has no exciting effects on the central nervous system. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| BAMIFIX Tablet | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
